🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether use of an ultra-high sens...
Status
Terminated
Location
John Radcliffe Hospital
Start Date
2020-09-21
Trial ID
NCT04556929
The MIRROR study is a prospective, single center phase I feasibility and do...
Status
Unknown
Location
UMCG
Start Date
2023-05-05
Trial ID
NCT05929456
Treatments Being Tested
RATIONALE: Imaging procedures that use aminolevulinic acid (ALA) may help f...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2009-12-08
Trial ID
NCT00752323
Treatments Being Tested
Pilot study of the feasibility of an innovative multimodal treatment combin...
Status
Recruiting
Location
Institut Coeur-Poumon, CHU
Start Date
2022-05-09
Trial ID
NCT04400539
Treatments Being Tested
The goal of this observational study is to evaluate disease-free survival (...
Status
Unknown
Location
Sociedad de Lucha Contra el Cáncer
Start Date
2023-06-01
Trial ID
NCT05850377
This post-market clinical follow-up (PMCF) study aims to confirm the safety...
Status
Not Yet Recruiting
Location
Unidade Local de Saúde de São João
Start Date
2026-02-01
Trial ID
NCT07366892
In this prospective, open, single-armed, multicenter, phase II study for ap...
Status
Completed
Location
Universitätsklinikum Augsburg, Klinik für Neurochirurgie
Start Date
2020-09-25
Trial ID
NCT04738162
Treatments Being Tested
Gliomas are tumors that occur in all ages; they include the most common mal...
Status
Recruiting
Location
Kuopio University Hospital
Start Date
2024-09-30
Trial ID
NCT06740097
Treatments Being Tested
During brain tumor surgery, it can be difficult for surgeons to distinguish...
Status
Completed
Location
Clinical Trial Center, Alessandria, Piedmont 151121
Start Date
2025-09-15
Trial ID
NCT07499141
Treatments Being Tested